首页> 外文期刊>Scientific reports. >Recurrence Rates and Risk Factors for Primary Giant Cell Tumors around the Knee: A Multicentre Retrospective Study in China
【24h】

Recurrence Rates and Risk Factors for Primary Giant Cell Tumors around the Knee: A Multicentre Retrospective Study in China

机译:膝关节周围原发性巨细胞肿瘤的复发率和危险因素:中国的多中心回顾性研究

获取原文
获取外文期刊封面目录资料

摘要

Giant cell tumors of the bone (GCTBs) are commonly diagnosed in Asian populations, usually around the knee. Herein, we aimed to determine the clinical characteristics, local recurrence rates, and relevant risk factors of primary GCTB around the knee. Univariate and multivariate survival analyses were used to identify the risk factors for local recurrence. Four hundred ten patients with primary GCTB around the knee, treated between March 2000 and June 2014, were recruited from 7 institutions in China. The overall local recurrence rate was 23.4%, but was higher in patients aged 20–39 years (28.5%; P?=?0.039). The local recurrence rate was the highest in patients treated with intralesional curettage (53.4%), and the lowest in those treated with resection (4.9%). We found a higher risk of tumor recurrence in the proximal fibula compared to the distal femur (hazard ratio: 28.52, 95% confidence interval: 5.88–138.39; P??0.0001), and in patients treated with curettage compared to those treated with resection (hazard ratio: 12.07, 95% confidence interval: 4.99–29.18; P??0.0001). Thus, the tumor location must be considered when selecting the optimal surgical treatment approach to reduce the risk of local recurrence and preserve joint function, especially in young patients.
机译:骨骼(GCTB)的巨细胞肿瘤通常在亚洲群体中诊断出来,通常在膝盖周围。在此,我们旨在确定膝关节周围原发性GCTB的临床特征,局部复发率和相关危险因素。单变量和多变量存活分析用于识别局部复发的危险因素。膝关节周围有四百次患有膝盖的主要GCTB患者,于2000年至2014年3月至6月,于2014年3月至2014年6月,于中国7个机构招募。整体局部复发率为23.4%,但患者20-39岁的患者较高(28.5%; P?= 0.039)。局部复发率是患者用腔内刮宫(53.4%)治疗的患者中最高,并且在切除术治疗的那些中最低(4.9%)。与远端股骨相比切除(危险比:12.07,95%置信区间:4.99-29.18; P?<0.0001)。 Thus, the tumor location must be considered when selecting the optimal surgical treatment approach to reduce the risk of local recurrence and preserve joint function, especially in young patients.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号